These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 26916953)

  • 21. CD44s and CD44v6 in diagnosis and prognosis of human bladder cancer.
    Omran OM; Ata HS
    Ultrastruct Pathol; 2012 May; 36(3):145-52. PubMed ID: 22559040
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Possible role of telomerase and sFas in pathogenesis of various bladder lesions associated with schistosomiasis.
    Shaker OG; Hammam O; Salehd A; el-Leithy T; Wishahi M
    Clin Biochem; 2009 Jun; 42(9):864-72. PubMed ID: 19272297
    [TBL] [Abstract][Full Text] [Related]  

  • 23. mTOR signaling pathway in penile squamous cell carcinoma: pmTOR and peIF4E over expression correlate with aggressive tumor behavior.
    Ferrandiz-Pulido C; Masferrer E; Toll A; Hernandez-Losa J; Mojal S; Pujol RM; Ramon y Cajal S; de Torres I; Garcia-Patos V
    J Urol; 2013 Dec; 190(6):2288-95. PubMed ID: 23764082
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of transforming growth factor beta1 and its receptors in normal human urothelium and human transitional cell carcinomas.
    Izadifar V; de Boer WI; Muscatelli-Groux B; Maillé P; van der Kwast TH; Chopin DK
    Hum Pathol; 1999 Apr; 30(4):372-7. PubMed ID: 10208456
    [TBL] [Abstract][Full Text] [Related]  

  • 25. TGF-B1 pathway as biological marker of bladder carcinoma schistosomal and non-schistosomal.
    Shaker O; Hammam O; Wishahi M; Roshdi M
    Urol Oncol; 2013 Apr; 31(3):372-8. PubMed ID: 21429769
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunohistochemical expression of p63, p53 and MIB-1 in urinary bladder carcinoma. A tissue microarray study of 158 cases.
    Compérat E; Camparo P; Haus R; Chartier-Kastler E; Bart S; Delcourt A; Houlgatte A; François R; Capron F; Vieillefond A
    Virchows Arch; 2006 Mar; 448(3):319-24. PubMed ID: 16283378
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CD10 and E-cad expression in urinary bladder urothelial and squamous cell carcinoma.
    Omran OM
    J Environ Pathol Toxicol Oncol; 2012; 31(3):203-12. PubMed ID: 23339695
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tumor markers of bladder cancer: the schistosomal bladder tumors versus non-schistosomal bladder tumors.
    Abdulamir AS; Hafidh RR; Kadhim HS; Abubakar F
    J Exp Clin Cancer Res; 2009 Feb; 28(1):27. PubMed ID: 19243595
    [TBL] [Abstract][Full Text] [Related]  

  • 29. H-RAS mutation is a key molecular feature of pediatric urothelial bladder cancer. A detailed report of three cases.
    Castillo-Martin M; Collazo Lorduy A; Gladoun N; Hyun G; Cordon-Cardo C
    J Pediatr Urol; 2016 Apr; 12(2):91.e1-7. PubMed ID: 26522772
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human Epidermal Growth Factor Receptor 2 Overexpression in Micropapillary and Other Variants of Urothelial Carcinoma.
    Behzatoğlu K; Yörükoğlu K; Demir H; Bal N
    Eur Urol Focus; 2018 Apr; 4(3):399-404. PubMed ID: 28753766
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Urachal carcinomas of the nonglandular type: salient features and considerations in pathologic diagnosis.
    Paner GP; Barkan GA; Mehta V; Sirintrapun SJ; Tsuzuki T; Sebo TJ; Jimenez RE
    Am J Surg Pathol; 2012 Mar; 36(3):432-42. PubMed ID: 22301493
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inducing cell proliferation inhibition and apoptosis via silencing Dicer, Drosha, and Exportin 5 in urothelial carcinoma of the bladder.
    Han Y; Liu Y; Gui Y; Cai Z
    J Surg Oncol; 2013 Feb; 107(2):201-5. PubMed ID: 22766726
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Placental S100 (S100P) and GATA3: markers for transitional epithelium and urothelial carcinoma discovered by complementary DNA microarray.
    Higgins JP; Kaygusuz G; Wang L; Montgomery K; Mason V; Zhu SX; Marinelli RJ; Presti JC; van de Rijn M; Brooks JD
    Am J Surg Pathol; 2007 May; 31(5):673-80. PubMed ID: 17460449
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PI3K/AKT pathway activation in bladder carcinogenesis.
    Calderaro J; Rebouissou S; de Koning L; Masmoudi A; Hérault A; Dubois T; Maille P; Soyeux P; Sibony M; de la Taille A; Vordos D; Lebret T; Radvanyi F; Allory Y
    Int J Cancer; 2014 Apr; 134(8):1776-84. PubMed ID: 24122582
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression status and prognostic significance of mammalian target of rapamycin pathway members in urothelial carcinoma of urinary bladder after cystectomy.
    Schultz L; Albadine R; Hicks J; Jadallah S; DeMarzo AM; Chen YB; Nielsen ME; Gonzalgo ML; Sidransky D; Schoenberg M; Netto GJ
    Cancer; 2010 Dec; 116(23):5517-26. PubMed ID: 20939013
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phosphatidylinositol 3'-kinase, mTOR, and glycogen synthase kinase-3β mediated regulation of p21 in human urothelial carcinoma cells.
    Yohn NL; Bingaman CN; DuMont AL; Yoo LI
    BMC Urol; 2011 Aug; 11():19. PubMed ID: 21864408
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Elevated oxidative stress and DNA damage and repair levels in urinary bladder carcinomas associated with schistosomiasis.
    Salim EI; Morimura K; Menesi A; El-Lity M; Fukushima S; Wanibuchi H
    Int J Cancer; 2008 Aug; 123(3):601-8. PubMed ID: 18478569
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High expression of polo-like kinase 1 is associated with the metastasis and recurrence in urothelial carcinoma of bladder.
    Zhang Z; Zhang G; Kong C
    Urol Oncol; 2013 Oct; 31(7):1222-30. PubMed ID: 22192978
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ARID1A immunohistochemistry improves outcome prediction in invasive urothelial carcinoma of urinary bladder.
    Faraj SF; Chaux A; Gonzalez-Roibon N; Munari E; Ellis C; Driscoll T; Schoenberg MP; Bivalacqua TJ; Shih IeM; Netto GJ
    Hum Pathol; 2014 Nov; 45(11):2233-9. PubMed ID: 25175170
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Proteomics and immunohistochemistry define some of the steps involved in the squamous differentiation of the bladder transitional epithelium: a novel strategy for identifying metaplastic lesions.
    Celis JE; Celis P; Ostergaard M; Basse B; Lauridsen JB; Ratz G; Rasmussen HH; Orntoft TF; Hein B; Wolf H; Celis A
    Cancer Res; 1999 Jun; 59(12):3003-9. PubMed ID: 10383167
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.